Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Medical Research
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Diabetes | Research

Bibliometric and visual analysis of diabetes mellitus and pyroptosis from 2011 to 2022

Authors: Xiaodong Li, Xiaojuan Su, Fenglin Xia, Jing Qiu, Jiaqi Zhang, Haiyan Wu, Xuejun Xie, Mingchao Xu

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Objective

To visualize and analyze the published literature on diabetes mellitus and pyroptosis based on a bibliometric approach, so as to provide a comprehensive picture of the hot research directions and dynamic progress in this field.

Methods

This study was based on the web of science core collection database to conduct a comprehensive search of the published literature in the field of diabetes mellitus and Pyroptosis from January 1985 to August 2022, including the published research literature in this field, as well as a visual analysis of the number of citations, year of publication, journal, author, research institution, country, and research topic.

Results

A total of 139 literature on research related to diabetes mellitus and cellular scorch from 2011 to 2022 were retrieved, with a total of 3009 citations and a maximum of 255 citations for a single article, which had a first author Schmid-Burgk, JL The first author of this article is from Germany; among 20 publishing countries, China leads with 100 articles; among 222 publishing institutions, Harbin Medical University leads with 18 articles and 184 citations; among 980 authors, Chen, X from China tops the list of high-impact authors with 5 articles and 29 citations. Among the 98 journals, "CELL DEATH DISEASE" ranked first in both volume and high-impact journals with 4 articles and 29 citations. Among 349 keywords, "pyroptosis" ranked first with a cumulative frequency of 65 times. The cluster analysis was divided into three categories, chronic complications of diabetes mellitus and pyroptosis (67 articles), diabetes mellitus and pyroptosis (60 articles), and diabetes mellitus combined with other diseases and pyroptosis (12 articles), and the number of articles related to diabetes mellitus and its chronic complications increased rapidly from 2019, among which, diabetic cardiomyopathy (27 articles) had the highest number of articles.

Conclusions

Based on a comprehensive analysis of published literature in the field of diabetes mellitus and pyroptosis from 2011 to 2022, this study achieved a visual analysis of studies with significant and outstanding contributions to the field, thus framing a picture showing the development and changes in the field. At the same time, this study provides research information and direction for clinicians and investigators to conduct diabetes mellitus and pyroptosis-related research in the future.
Literature
1.
De Candia P, Prattichizzo F, Garavelli S, et al. Type 2 diabetes: how much of an autoimmune disease. Front Endocrinol. 2019;10:451.CrossRef
2.
Bolívar BE, Vogel TP, Bouchier-Hayes L. Inflammatory caspase regulation: maintaining balance between inflammation and cell death in health and disease. FEBS J. 2019;286(14):2628–44.PubMedPubMedCentral
3.
Tsuchiya K. Inflammasome-associated cell death: pyroptosis, apoptosis, and physiological implications. Microbiol Immunol. 2020;64(4):252–69.PubMedCrossRef
4.
Verdonck S, Nemegeer J, Vandenabeele P, et al. Viral manipulation of host cell necroptosis and pyroptosis. Trends Microbiol. 2022;30(6):593–605.PubMedCrossRef
5.
Abouzid M, Główka AK, Karaźniewicz-Łada M. Trend research of vitamin D receptor: bibliometric analysis. Health Informatics J. 2021;27(4):14604582211043158.PubMedCrossRef
6.
Schmid-Burgk J, Chauhan D, Schmidt T, et al. A genome-wide CRISPR (clustered regularly interspaced short palindromic repeats) screen identifies NEK7 as an essential component of NLRP3 inflammasome activation. J Biol Chem. 2016;291(1):103–9.PubMedCrossRef
7.
Li X, Du N, Zhang Q, et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 2014;5: e1479.PubMedPubMedCentralCrossRef
8.
Qiu Z, Lei S, Zhao B, et al. NLRP3 Inflammasome activation-mediated pyroptosis aggravates myocardial ischemia/reperfusion injury in diabetic rats. Oxid Med Cell Longev. 2017;2017:9743280.PubMedPubMedCentralCrossRef
9.
10.
Li X, Zeng L, Cao C, et al. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy. Exp Cell Res. 2017;350(2):327–35.PubMedCrossRef
11.
Giordano A, Murano I, Mondini E, et al. Obese adipocytes show ultrastructural features of stressed cells and die of pyroptosis. J Lipid Res. 2013;54(9):2423–36.PubMedPubMedCentralCrossRef
12.
Yang F, Qin Y, Wang Y, et al. Metformin inhibits the NLRP3 inflammasome via AMPK/mTOR-dependent effects in diabetic cardiomyopathy. Int J Biol Sci. 2019;15(5):1010–9.PubMedPubMedCentralCrossRef
13.
Yang F, Qin Y, Lv J, et al. Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy. Cell Death Dis. 2018;9(10):1000.PubMedPubMedCentralCrossRef
14.
Qiu Z, He Y, Ming H, et al. Lipopolysaccharide (LPS) aggravates high glucose- and hypoxia/reoxygenation-induced injury through activating ROS-dependent NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. J Diabetes Res. 2019;2019:8151836.PubMedPubMedCentralCrossRef
15.
Yang F, Qin Y, Wang Y, et al. LncRNA KCNQ1OT1 mediates pyroptosis in diabetic cardiomyopathy. Cell Physiol Biochem. 2018;50(4):1230–44.PubMedCrossRef
16.
Ali MF, Dasari H, Van Keulen VP, et al. Canonical stimulation of the NLRP3 inflammasome by fungal antigens links innate and adaptive B-lymphocyte responses by modulating IL-1β and IgM production. Front Immunol. 2017;8:1504.PubMedPubMedCentralCrossRef
17.
18.
Kayagaki N, Wong M, Stowe I, et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science. 2013;341(6151):1246–9.PubMedCrossRef
19.
Zhu M, Kang Y, Xue Y, et al. Red raspberries suppress NLRP3 inflammasome and attenuate metabolic abnormalities in diet-induced obese mice. J Nutr Biochem. 2018;53:96–103.PubMedCrossRef
20.
Carlos D, Costa F, Pereira C, et al. Mitochondrial DNA activates the NLRP3 inflammasome and predisposes to type 1 diabetes in murine model. Front Immunol. 2017;8:164.PubMedPubMedCentralCrossRef
21.
Iannantuoni F, Diaz-Morales N, Escribano-Lopez I, et al. Does glycemic control modulate the impairment of NLRP3 inflammasome activation in type 2 diabetes? Antioxid Redox Signal. 2019;30(2):232–40.PubMedCrossRef
22.
Sun X, Hao H, Han Q, et al. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Res Ther. 2017;8(1):241.PubMedPubMedCentralCrossRef
23.
Chen C, Ma X, Yang C, et al. Hypoxia potentiates LPS-induced inflammatory response and increases cell death by promoting NLRP3 inflammasome activation in pancreatic β cells. Biochem Biophys Res Commun. 2018;495(4):2512–8.PubMedCrossRef
24.
Wan T, Li X, Li Y. The role of TRIM family proteins in autophagy, pyroptosis, and diabetes mellitus. Cell Biol Int. 2021;45(5):913–26.PubMedCrossRef
25.
26.
Cohen S, Lee D, Zhai B, et al. Trim32 reduces PI3K-Akt-FoxO signaling in muscle atrophy by promoting plakoglobin-PI3K dissociation. J Cell Biol. 2014;204(5):747–58.PubMedPubMedCentralCrossRef
27.
Montori-Grau M, Pedreira-Casahuga R, Boyer-Díaz Z, et al. GNIP1 E3 ubiquitin ligase is a novel player in regulating glycogen metabolism in skeletal muscle. Metabolism. 2018;83:177–87.PubMedCrossRef
28.
Song R, Peng W, Zhang Y, et al. Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature. 2013;494(7437):375–9.PubMedCrossRef
29.
Li Y, Ren D, Shen Y, et al. Altered DNA methylation of TRIM13 in diabetic nephropathy suppresses mesangial collagen synthesis by promoting ubiquitination of CHOP. EBioMedicine. 2020;51: 102582.PubMedPubMedCentralCrossRef
30.
Lecker S, Jagoe R, Gilbert A, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 2004;18(1):39–51.PubMedCrossRef
31.
Prandi F, Evangelista I, Sergi D, et al. Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants. Heart Fail Rev. 2022;28(3):597–606.PubMedCrossRef
32.
Prabhu S, Frangogiannis NJ. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119(1):91–112.PubMedPubMedCentralCrossRef
33.
Zhang X, Pan L, Yang K, et al. H3 relaxin protects against myocardial injury in experimental diabetic cardiomyopathy by inhibiting myocardial apoptosis. Fibros Inflamm Cell Physiol Biochem. 2017;43(4):1311–24.CrossRef
34.
Zhang H, Chen X, Zong B, et al. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation. J Cell Mol Med. 2018;22(9):4437–48.PubMedPubMedCentralCrossRef
35.
Yan M, Li L, Wang Q, et al. The Chinese herbal medicine Fufang Zhenzhu Tiaozhi protects against diabetic cardiomyopathy by alleviating cardiac lipotoxicity-induced oxidative stress and NLRP3-dependent inflammasome activation. Biomed Pharmacother. 2022;148: 112709.PubMedCrossRef
36.
Yadav S, Kambis T, Kar S, et al. MMP9 mediates acute hyperglycemia-induced human cardiac stem cell death by upregulating apoptosis and pyroptosis in vitro. Cell Death Dis. 2020;11(3):186.PubMedPubMedCentralCrossRef
37.
Cai Z, Yuan S, Luan X, et al. Pyroptosis-related inflammasome pathway: a new therapeutic target for diabetic cardiomyopathy. Front Pharmacol. 2022;13: 842313.PubMedPubMedCentralCrossRef
38.
39.
Wei H, Bu R, Yang Q, et al. Exendin-4 protects against hyperglycemia-induced cardiomyocyte pyroptosis via the AMPK-TXNIP pathway. J Diabetes Res. 2019;2019:8905917.PubMedPubMedCentralCrossRef
40.
41.
Li H, Shi Y, Wang X, et al. Piceatannol alleviates inflammation and oxidative stress via modulation of the Nrf2/HO-1 and NF-κB pathways in diabetic cardiomyopathy. Chem Biol Interact. 2019;310: 108754.PubMedCrossRef
42.
Zou R, Nie C, Pan S, et al. Co-administration of hydrogen and metformin exerts cardioprotective effects by inhibiting pyroptosis and fibrosis in diabetic cardiomyopathy. Free Radic Biol Med. 2022;183:35–50.PubMedCrossRef
43.
Yang F, Li A, Qin Y, et al. A novel circular RNA mediates pyroptosis of diabetic cardiomyopathy by functioning as a competing endogenous RNA. Mol Ther Nucleic Acids. 2019;17:636–43.PubMedPubMedCentralCrossRef
44.
Jeyabal P, Thandavarayan R, Joladarashi D, et al. MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1. Biochem Biophys Res Commun. 2016;471(4):423–9.PubMedPubMedCentralCrossRef
45.
Zhang J, Yu R, Wu F, et al. BMP-2 alleviates heart failure with type 2 diabetes mellitus and doxorubicin-induced AC16 cell injury by inhibiting NLRP3 inflammasome-mediated pyroptosis. Exp Ther Med. 2021;22(2):897.PubMedPubMedCentralCrossRef
46.
Elmadbouh I, Singla DK. BMP-7 attenuates inflammation-induced pyroptosis and improves cardiac repair in diabetic cardiomyopathy. Cells. 2021;10(10):2640.PubMedPubMedCentralCrossRef
47.
Dagar N, Das P, Bisht P, et al. Diabetic nephropathy: a twisted thread to unravel. Life Sci. 2021;278: 119635.PubMedCrossRef
48.
Ni WJ, Tang LQ, Wei W. Research progress in signalling pathway in diabetic nephropathy. Diabetes Metab Res Rev. 2015;31(3):221–33.PubMedCrossRef
49.
Liu B, Tang T, Lv L, et al. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 2018;93(3):568–79.PubMedCrossRef
50.
Warren A, Knudsen S, Cooper ME. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies. Expert Opin Ther Targets. 2019;23(7):579–91.PubMedCrossRef
51.
Yang X, Wang Y, Gao G. High glucose induces rat mesangial cells proliferation and MCP-1 expression via ROS-mediated activation of NF-κB pathway, which is inhibited by eleutheroside E. J Recept Signal Transduct Res. 2016;36(2):152–7.PubMedCrossRef
52.
Xu L, Shen P, Bi Y, et al. Danshen injection ameliorates STZ-induced diabetic nephropathy in association with suppression of oxidative stress, pro-inflammatory factors and fibrosis. Int Immunopharmacol. 2016;38:385–94.PubMedCrossRef
53.
Mulay SR. Multifactorial functions of the inflammasome component NLRP3 in pathogenesis of chronic kidney diseases. Kidney Int. 2019;96(1):58–66.PubMedCrossRef
54.
Zhang C, Boini K, Xia M, et al. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension. 2012;60(1):154–62.PubMedCrossRef
55.
Zhan J, Huang H, Huang C, et al. Long non-coding RNA NEAT1 regulates pyroptosis in diabetic nephropathy via mediating the miR-34c/NLRP3 axis. Kidney Blood Press Res. 2020;45(4):589–602.PubMedCrossRef
56.
Wang Y, Gou R, Yu L, et al. Activation of the NLRC4 inflammasome in renal tubular epithelial cell injury in diabetic nephropathy. Exp Ther Med. 2021;22(2):814.PubMedPubMedCentralCrossRef
57.
Cheng Q, Pan J, Zhou Z, et al. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy. Acta Pharmacol Sin. 2021;42(6):954–63.PubMedCrossRef
58.
Chen F, Wei G, Xu J, et al. Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome. BMC Complement Altern Med. 2018;18(1):192.PubMedPubMedCentralCrossRef
59.
Birnbaum Y, Bajaj M, Yang HC, et al. Combined SGLT2 and DPP4 inhibition reduces the activation of the Nlrp3/ASC inflammasome and attenuates the development of diabetic nephropathy in mice with type 2 diabetes. Cardiovasc Drugs Ther. 2018;32(2):135–45.PubMedCrossRef
60.
Liu C, Zhuo H, Ye M, et al. LncRNA MALAT1 promoted high glucose-induced pyroptosis of renal tubular epithelial cell by sponging miR-30c targeting for NLRP3. Kaohsiung J Med Sci. 2020;36(9):682–91.PubMedCrossRef
61.
Ding X, Jing N, Shen A, et al. MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20. J Endocrinol Invest. 2021;44(6):1175–84.PubMedCrossRef
62.
Li G, Qin Y, Qin S, et al. Circ_WBSCR17 aggravates inflammatory responses and fibrosis by targeting miR-185-5p/SOX6 regulatory axis in high glucose-induced human kidney tubular cells. Life Sci. 2020;259: 118269.PubMedCrossRef
63.
Xiaodong L, Xuejun X. GSDMD-mediated pyroptosis in retinal vascular inflammatory diseases: a review. Int Ophthalmol. 2022;43(4):1405–11.PubMedCrossRef
64.
Hammes HP. Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond. Diabetologia. 2018;61(1):29–38.PubMedCrossRef
65.
Srinivasan S, Dehghani C, Pritchard N, et al. Corneal and retinal neuronal degeneration in early stages of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58(14):6365–73.PubMedCrossRef
66.
67.
Chen H, Deng Y, Gan X, et al. NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma. Mol Neurodegener. 2020;15(1):26.PubMedPubMedCentralCrossRef
68.
Yin Y, Chen F, Wang W, et al. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: possible involvement of NLRP3 inflammasome and NF-κB signaling pathway. Mol Vis. 2017;23:242–50.PubMedPubMedCentral
69.
Trueblood K, Mohr S, Dubyak GR. Purinergic regulation of high-glucose-induced caspase-1 activation in the rat retinal Müller cell line rMC-1. Am J Physiol Cell Physiol. 2011;301(5):C1213-1223.PubMedPubMedCentralCrossRef
70.
Feenstra D, Yego EC, Mohr S. Modes of retinal cell death in diabetic retinopathy. J Clin Exp Ophthalmol. 2013;4(5):298.PubMedPubMedCentral
71.
72.
Busik J, Mohr S, Grant MJD. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes. 2008;57(7):1952–65.PubMedPubMedCentralCrossRef
73.
Hartsock M, Cho H, Wu L, et al. A mouse model of retinal ischemia-reperfusion injury through elevation of intraocular pressure. J Vis Exp. 2016;14(113): e54065.
74.
Wan P, Su W, Zhang Y, et al. LncRNA H19 initiates microglial pyroptosis and neuronal death in retinal ischemia/reperfusion injury. Cell Death Differ. 2020;27(1):176–91.PubMedCrossRef
75.
Huang L, You J, Yao Y, et al. High glucose induces pyroptosis of retinal microglia through NLPR3 inflammasome signaling. Arq Bras Oftalmol. 2021;84(1):67–73.PubMed
76.
Gan J, Huang M, Lan G, et al. High glucose induces the loss of retinal pericytes partly via NLRP3-caspase-1-GSDMD-mediated pyroptosis. Biomed Res Int. 2020;2020:4510628.PubMedPubMedCentralCrossRef
77.
Kong H, Zhao H, Chen T, et al. Targeted P2X7/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy. Cell Death Dis. 2022;13(4):336.PubMedPubMedCentralCrossRef
78.
Yang K, Liu J, Zhang X, et al. H3 relaxin alleviates migration, apoptosis and pyroptosis through P2X7R-mediated nucleotide binding oligomerization domain-like receptor protein 3 inflammasome activation in retinopathy induced by hyperglycemia. Front Pharmacol. 2020;11: 603689.PubMedPubMedCentralCrossRef
79.
Wang Y, Tao J, Yao YJH. Prostaglandin E2 activates NLRP3 inflammasome in endothelial cells to promote diabetic retinopathy. Horm Metab Res. 2018;50(9):704–10.PubMedCrossRef
80.
Su X, Zhou P, Qi Y. Down-regulation of LCN2 attenuates retinal vascular dysfunction and caspase-1-mediated pyroptosis in diabetes mellitus. Ann Transl Med. 2022;10(12):695.PubMedPubMedCentralCrossRef
81.
Huang C, Qi P, Cui H, et al. CircFAT1 regulates retinal pigment epithelial cell pyroptosis and autophagy via mediating m6A reader protein YTHDF2 expression in diabetic retinopathy. Exp Eye Res. 2022;222:109152.PubMedCrossRef
82.
Liang G, Luo Y, Wei R, et al. CircZNF532 knockdown protects retinal pigment epithelial cells against high glucose-induced apoptosis and pyroptosis by regulating the miR-20b-5p/STAT3 axis. J Diabetes Investig. 2022;13(5):781–95.PubMedPubMedCentralCrossRef
83.
Gu C, Zhang H, Li Q, et al. MiR-192 attenuates high glucose-induced pyroptosis in retinal pigment epithelial cells via inflammasome modulation. Bioengineered. 2022;13(4):10362–72.PubMedPubMedCentralCrossRef
84.
Li W, Yang S, Chen G, et al. MiR-200c-3p regulates pyroptosis by targeting SLC30A7 in diabetic retinopathy. Hum Exp Toxicol. 2022;41:9603271221099588.PubMedCrossRef
85.
Yu X, Ma X, Lin W, et al. Long noncoding RNA MIAT regulates primary human retinal pericyte pyroptosis by modulating miR-342–3p targeting of CASP1 in diabetic retinopathy. Exp Eye Res. 2021;202: 108300.PubMedCrossRef
86.
Cheng Y, Chu L, Chen J, et al. Loganin attenuates high glucose-induced schwann cells pyroptosis by inhibiting ROS generation and NLRP3 inflammasome activation. Cells. 2020;9(9):1948.PubMedPubMedCentralCrossRef
87.
Preshaw P, Alba A, Herrera D, et al. Periodontitis and diabetes: a two-way relationship. Diabetologia. 2012;55(1):21–31.PubMedCrossRef
88.
Yang L, Liu J, Shan Q, et al. High glucose inhibits proliferation and differentiation of osteoblast in alveolar bone by inducing pyroptosis. Biochem Biophys Res Commun. 2020;522(2):471–8.PubMedCrossRef
89.
Zhou X, Wang Q, Nie L, et al. Metformin ameliorates the NLPP3 inflammasome mediated pyroptosis by inhibiting the expression of NEK7 in diabetic periodontitis. Arch Oral Biol. 2020;116: 104763.PubMedCrossRef
90.
Zhao P, Yue Z, Nie L, et al. Hyperglycaemia-associated macrophage pyroptosis accelerates periodontal inflamm-aging. J Clin Periodontol. 2021;48(10):1379–92.PubMedCrossRef
91.
Nie L, Zhao P, Yue Z, et al. Diabetes induces macrophage dysfunction through cytoplasmic dsDNA/AIM2 associated pyroptosis. J Leukoc Biol. 2021;110(3):497–510.PubMedCrossRef
92.
93.
94.
Wan L, Bai X, Zhou Q, et al. The advanced glycation end-products (AGEs)/ROS/NLRP3 inflammasome axis contributes to delayed diabetic corneal wound healing and nerve regeneration. Int J Biol Sci. 2022;18(2):809–25.PubMedPubMedCentralCrossRef
95.
Ma C, Luo H, Liu B, et al. Long noncoding RNAs: a new player in the prevention and treatment of diabetic cardiomyopathy? Diabetes Metab Res Rev. 2018;34(8): e3056.PubMedCrossRef
96.
Zhang Y, Song Z, Li X, et al. Long noncoding RNA KCNQ1OT1 induces pyroptosis in diabetic corneal endothelial keratopathy. Am J Physiol Cell Physiol. 2020;318(2):C346–59.PubMedCrossRef
97.
Zhang J, Chen C, Hua S, et al. An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer’s disease. Diabetes Res Clin Pract. 2017;124:41–7.PubMedCrossRef
98.
Goldwaser E, Acharya N, Sarkar A, et al. Breakdown of the cerebrovasculature and blood-brain barrier: a mechanistic link between diabetes mellitus and Alzheimer’s disease. J Alzheimers Dis. 2016;54(2):445–56.PubMedCrossRef
99.
Chi W, Chen H, Li F, et al. HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma. J Neuroinflammation. 2015;12:137.PubMedPubMedCentralCrossRef
100.
Zou S, Zou Q, Xiong W, et al. Brain microvascular endothelial cell-derived HMGB1 facilitates monocyte adhesion and transmigration to promote JEV neuroinvasion. Front Cell Infect Microbiol. 2021;11: 701820.PubMedPubMedCentralCrossRef
101.
Zhang T, Sun L, Wang T, et al. Gestational exposure to PM leads to cognitive dysfunction in mice offspring via promoting HMGB1-NLRP3 axis mediated hippocampal inflammation. Ecotoxicol Environ Saf. 2021;223: 112617.PubMedCrossRef
102.
Guo X, Shi Y, Du P, et al. HMGB1/TLR4 promotes apoptosis and reduces autophagy of hippocampal neurons in diabetes combined with OSA. Life Sci. 2019;239: 117020.PubMedCrossRef
103.
Tu Y, Guo C, Song F, et al. Mild hypothermia alleviates diabetes aggravated cerebral ischemic injury via activating autophagy and inhibiting pyroptosis. Brain Res Bull. 2019;150:1–12.PubMedCrossRef
104.
Wang J, Wang L, Zhou J, et al. The protective effect of formononetin on cognitive impairment in streptozotocin (STZ)-induced diabetic mice. Biomed Pharmacother. 2018;106:1250–7.PubMedCrossRef
Metadata
Title
Bibliometric and visual analysis of diabetes mellitus and pyroptosis from 2011 to 2022
Authors
Xiaodong Li
Xiaojuan Su
Fenglin Xia
Jing Qiu
Jiaqi Zhang
Haiyan Wu
Xuejun Xie
Mingchao Xu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01175-7

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue

Review

Immunology in COPD and the use of combustible cigarettes and heated tobacco products

Research

Hospitalized patients received furosemide undergoing acute kidney injury: the risk and prediction tool

Review

Bacterial lipopolysaccharide-induced endothelial activation and dysfunction: a new predictive and therapeutic paradigm for sepsis

Correction

Correction: Protective effects of paraoxonase-1, vitamin E and selenium, and oxidative stress index on the susceptibility of low density lipoprotein to oxidation in diabetic patients with/without coronary artery disease

Research

Relationship between neutrophil to lymphocyte ratio and diabetic peripheral neuropathy: a systematic review and meta-analysis

Research

Factors influencing the degree of disability in patients with neuromyelitis optica spectrum disorders